Published in Medical Device Business Week, February 28th, 2007
This landmark patent permits construction of mini-chromosomes as vectors for plant and animal cells and includes techniques for creating transgenic plants using engineered mini-chromosomes. Importantly, this patent is not specific to a particular plant species, but instead provides Chromatin with exclusive rights to use mini-chromosome technology in all plants.
The issued patent covers technology developed by doctors Daphne Preuss,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week